Praneet

“So yeah, I wanted to ask in terms of IB, I understand that we've been talking about IB for like last two, three quarters, at least in terms of the success it has shown in terms of vertical teams.”

“So, you mentioned the fact that you are focusing on high-value products. What is that meaning? Like, are we changing our strategy in terms of focusing on basic types to this?”

“So, I want to understand in terms of, you mentioned that there are a lot more products, there are a lot of sales, but what is the company exactly doing to get higher performance and higher visibility because we're going to see sometimes the visibility has suddenly increased, right?”

“So I wanted to understand in terms of the Alina effect that everyone's been really talking about, has it transpired in the ground or how is the sentiment on the ground as far as this point of time?”

“So, one question I had regarding our focus on generics. You mentioned that in our last calls that we've done well in our patented products, but in generics, there was a space which you wanted to expand in.”